Circulating TGF-β levels were noted to be elevated in multiple pathological conditions including breast cancer[40], non-small cell lung cancer[41], hepatocellular carcinoma[42], and dilated cardiomyopathy[43]. Here, TGFB1 is linked to non-small cell lung carcinoma.